Under construction – not a live service
Sign in
Taking people in AustriaNo phase

Registry study following adults with mycobacterial lung infections in Austria

Collects data on patients with tuberculosis or nontuberculous mycobacterial lung infections during routine care.

Plain-language title generated from the registry record
Registry title: Mycobacteria Registry Study: Prospective Observational Study in Austria

Key facts

Where
Vienna, AustriaSee the 3 sites

Where in Austria

  • Klinik HietzingVienna, AustriaTaking people
  • Klinik PenzingVienna, AustriaTaking people
  • Ludwig Boltzmann Institut for Lung HealthVienna, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ludwig Boltzmann Institute for Lung Health
Trial code
NCT06522347
Record updated
26 July 2024
Original description
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:Read full original descriptionShow less

Mycobacteria Registry Study: Prospective Observational Study in Austria

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

Inclusion: patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection; individuals aged 18 years or older; written informed consent.

Exclusion: to not comprehend and rightfully judge participation.

ClinicalTrials.gov NCT06522347